304 related articles for article (PubMed ID: 34479017)
1. Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs.
Rath S; Perikala V; Jena AB; Dandapat J
Biomed Pharmacother; 2021 Nov; 143():112095. PubMed ID: 34479017
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications.
Kianmehr A; Faraoni I; Kucuk O; Mahrooz A
Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1587-1598. PubMed ID: 33939044
[TBL] [Abstract][Full Text] [Related]
3. ACE2: from protection of liver disease to propagation of COVID-19.
Warner FJ; Rajapaksha H; Shackel N; Herath CB
Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2.
Elrashdy F; Redwan EM; Uversky VN
Infect Genet Evol; 2020 Nov; 85():104510. PubMed ID: 32853823
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus
Beacon TH; Delcuve GP; Davie JR
Genome; 2021 Apr; 64(4):386-399. PubMed ID: 33086021
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2, ACE2 expression, and systemic organ invasion.
Ashraf UM; Abokor AA; Edwards JM; Waigi EW; Royfman RS; Hasan SA; Smedlund KB; Hardy AMG; Chakravarti R; Koch LG
Physiol Genomics; 2021 Feb; 53(2):51-60. PubMed ID: 33275540
[TBL] [Abstract][Full Text] [Related]
7. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
Galanopoulos M; Doukatas A; Gazouli M
World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases.
Sharma RK; Li J; Krishnan S; Richards EM; Raizada MK; Mohandas R
Clin Sci (Lond); 2021 Jan; 135(1):1-17. PubMed ID: 33399851
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury.
Oz M; Lorke DE
Biomed Pharmacother; 2021 Apr; 136():111193. PubMed ID: 33461019
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
Verma D; Church TM; Swaminathan S
J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
[TBL] [Abstract][Full Text] [Related]
11. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.
Beyerstedt S; Casaro EB; Rangel ÉB
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):905-919. PubMed ID: 33389262
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
Shukla AK; Banerjee M
High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
Vieira C; Nery L; Martins L; Jabour L; Dias R; Simões E Silva AC
Curr Drug Targets; 2021; 22(3):254-281. PubMed ID: 33081670
[TBL] [Abstract][Full Text] [Related]
15. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D
Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662
[TBL] [Abstract][Full Text] [Related]
16. Population-Specific
Hashizume M; Gonzalez G; Ono C; Takashima A; Iwasaki M
Viruses; 2021 Jan; 13(1):. PubMed ID: 33418950
[TBL] [Abstract][Full Text] [Related]
17. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
[TBL] [Abstract][Full Text] [Related]
19. ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19.
Rezaei M; Ziai SA; Fakhri S; Pouriran R
J Cell Physiol; 2021 Apr; 236(4):2430-2442. PubMed ID: 32901940
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
Lite C; Ahmed SSSJ; Juliet M; Freddy AJ
Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33469663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
